Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Time to synergize mental health with brain health

Nature Mental Health volume 1, pages 441–443 (2023)Cite this article

Subjects

This Comment highlights the intertwined nature of mental and brain health and disease. Common genetic, environmental and lifestyle factors contribute to psychiatric and neurological disorders, which partially share neurocognitive and pathophysiological mechanisms. A call for a more dimensional, interdisciplinary approach can accelerate the development of robust approaches to research, prevention and intervention.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Common and interconnected levels of analysis across mental health and brain health fields and diseases.

References

  1. Ibanez, A. et al. World Psychiatry 13, 148–149 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Thibaut, F. Dialogues Clin. Neurosci. 20, 251–252 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Tian, Y. E. et al. JAMA Psychiatry 80, 567–576 (2023).

    Article  PubMed  Google Scholar 

  4. Craske, M. G. et al. Nat. Ment. Health 1, 12–24 (2023).

    Article  Google Scholar 

  5. Avan, A. & Hachinski, V. Alzheimers Dement. 18, 1396–1407 (2022).

    Article  PubMed  Google Scholar 

  6. Leffa, D. T. et al. Mol. Psychiatry 28, 1248–1255 (2023).

    Article  PubMed  Google Scholar 

  7. Qureshi, I. A. & Mehler, M. F. Handb. Clin. Neurol. 147, 43–58 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Vermeulen, R. et al. Science 367, 392–396 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Hsiao, Y. H. et al. J. Sleep Res. 26, 623–628 (2017).

    Article  PubMed  Google Scholar 

  10. Ibanez, A. et al. Soc. Neurosci. 13, 1–39 (2018).

    Article  PubMed  Google Scholar 

  11. Ibanez, A. Trends Cogn. Sci. 26, 1031–1034 (2022).

    Article  PubMed  Google Scholar 

  12. Migeot, J. A. et al. Trends Neurosci. 45, 838–853 (2022).

    Article  PubMed  Google Scholar 

  13. Khansari, P. S. & Sperlagh, B. Inflammopharmacology 20, 103–107 (2012).

    Article  PubMed  Google Scholar 

  14. Luppi, A. I. et al. Nat. Rev. Neurosci. 23, 767–768 (2022).

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from Takeda CW2680521; ANID/FONDECYT Regular (1210195, 1210176 and 1220995); ANID/FONDAP/15150012; and ReDLat: the National Institutes of Health and the Fogarty International Center (FIC), National Institutes of Aging (R01 AG057234), Alzheimer’s Association (SG-20-725707), Rainwater Charitable Foundation; and Global Brain Health Institute (all grants to A.I.). The contents of this publication are solely the authors’ responsibility and do not represent the official views of these institutions.

Author information

Authors and Affiliations

  1. Global Brain Health Institute (GBHI), University of California San Francisco (UCSF), California, CA, USA

    Agustin Ibanez

  2. Trinity College Dublin (TCD), Dublin, Ireland

    Agustin Ibanez

  3. Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile

    Agustin Ibanez

  4. Department of Pharmacology, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil

    Eduardo R. Zimmer

  5. Graduate Program in Biological Sciences: Biochemistry (PPGBioq) and Pharmacology and Therapeutics (PPGFT), UFRGS, Porto Alegre, Brazil

    Eduardo R. Zimmer

  6. McGill University Research Centre for Studies in Aging, McGill University, Montreal, Canada

    Eduardo R. Zimmer

  7. Brain Institute of Rio Grande do Sul, Pontíficia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil

    Eduardo R. Zimmer

Authors
  1. Agustin Ibanez
    View author publications

    Search author on:PubMed Google Scholar

  2. Eduardo R. Zimmer
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Agustin Ibanez.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature Mental Health thanks Joëlle Rüegg and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ibanez, A., Zimmer, E.R. Time to synergize mental health with brain health. Nat. Mental Health 1, 441–443 (2023). https://doi.org/10.1038/s44220-023-00086-0

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s44220-023-00086-0

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing